Bedsore Dressing Market Report: Trends, Forecast and Competitive Analysis to 2035

Bedsore Dressing Market

The future of the global bedsore dressing market looks promising with opportunities in the hospital, clinic, pharmacy, and online markets. The global bedsore dressing market is expected to reach an estimated $1.6 billion by 2035 from $1.3 billion in 2027 with a CAGR of 3.4% from 2027 to 2035. The major drivers for this market are the increasing prevalence of pressure ulcer patients, the rising demand for advanced wound care products, and the growing geriatric population requiring long term care.

• Lucintel forecasts that, within the type category, foam dressings is expected to witness the highest growth over the forecast period due to more effective at cushioning and absorbing exudate.
• Within the application category, hospital is expected to witness the highest growth over the forecast period due to increasing cases of pressure ulcers.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to increasing knowledge and awareness of public health in regards to preventing bedsores.

Emerging Trends in Bedsore Dressing Market

Between 2025 and 2027The market is expected to transition from the use of commodity gauze to more complex wound care products and surfaces. Different customers within the marketplace (e.g., hospitals, home and long-term care services) are requesting that wound care products be designed to facilitate less frequent product change and provide evidence to support wound healing. Lucintel believes that the request for more advanced wound care products will increase as reimbursement for wound care products becomes more stringent.

• Sustainability: Leading wound care product suppliers have significantly reduced the amount of plastic and dressing bulk to reduce the burden of product disposal; in addition, leading suppliers have removed latex from their product offerings. These supplier changes were brought about by the increasing emphasis by health care facilities on the sustainability of the products they purchase. Health care systems (e.g., hospitals) are placing more stringent requirements on the environmental impact of health care products and services.
• Digital Monitoring: During 2025, several suppliers of wound care products introduced systems that facilitate remote diagnostic and/or digital image transfer by health care personnel. These systems will transform wound care by offering health care product suppliers a means to enhance nursing staff productivity and/or provide evidence to support a given reimbursement level.
• Functional Products: In 2025, products with more complex and quicker acting wound healing properties (e.g., anti-microbial, and foam and hydrocolloid wound care products) were more effective and caused less trauma to the wounded skin, when compared to other, lower cost, products. These products facilitated less frequent product changes, and therefore, tended to be more reimbursable.
• Regional Supply Diversification: Buyers are qualifying more suppliers in North America, Europe and Asia from 2025 to 2027. This is due to chronic freight disruption and variability in input costs. With regard to the healthcare industry, this will result in more supply chain diversification and less reliance on a single country's supply. Dual sourcing is expected to improve supply chain resiliency for healthcare.
• Integration of Preventative Care: There is a trend to integrate preventative care into various services offered at healthcare facilities. For example, nutrition screenings and risk assessments are integrated with pressure injury prevention. Each year, 2.5 million pressure injuries occur in U.S. hospitals. Preventive measures are expected to lead to an increase in demand for products that help prevent pressure injuries and other skin injuries.

From 2025 to 2027, greater focus will be on products that help improve resource utilization, facilitate prevention of pressure injuries, and integrate with standardized procedures. Suppliers that help achieve prevention and timely treatment of pressure injuries and have a strong regional presence will be advantaged.

Recent Developments in the Bedsore Dressing Market

The bedsore dressing market is expected to be actively growing during the years 2025-2027, particularly due to the emphasis on prevention of pressure injuries in the hospital and healthcare setting, as well as in home healthcare. Additionally, there is expected to be an increased focus on products that minimize the time that staff is devoted to wound care. According to Lucintel, the focus on the use of products supported by clinical data will continue, and along with changes in the healthcare reimbursement policy, and the increasing average age of the population, will drive the market for advanced wound care products.

• Continuing The Trend of Combination Products: Several companies have acquired or licensed products to expand their offerings in the wound care market. In 2025, Convatec's Advanced Wound Care business was reported to have 5% revenue growth from combination products (February 2026). This trend, similar to combination products, will lead to a reduction in the number of suppliers of wound care products in the marketplace.
• Increased Capacity for Atraumatic Foam Dressings: Molnlycke announced in June 2025 that it was expanding its capacity for Mepilex by 20%. Increased capacity for advanced wound care products will lead to reduction in supply constraints and allow for the routine use of premium products in the marketplace.
• Cost Effectiveness Drives Reimbursement: Some payers will only cover higher cost dressings if there is evidence of a significant reduction in the development of Hospital Acquired Pressure Injuries (HAPIs) by the lower cost dressing. The Centres for Medicare and Medicaid Services (CMS) has announced that from 2025 onwards, it will adjust payments to U.S. hospitals based on their performance for improving the quality of services offered. This may also impact dressing reimbursement. It is expected that CMS will prefer dressings that promote wound healing and/or require fewer changes.
• Accelerated Digital Wound Assessment and Documentation: Increasingly, dressing manufacturers are partnering with manufacturers of digital imaging and measurement technology to package and market integrated products. Swift Medical's 2025 expansion of its onsite wound assessment program to over 2,000 hospitals is an example. Digital records will facilitate remote assessment and justification of product selection.
• Focus on Home Care: More dressings manufacturers are tailoring their products, education and distribution to ensure the target hospital-based staff appropriately prepare and educate patients about the use of the product once discharged. A 2026 partnership to supply 500,000 advanced dressings in Europe focused on the home care market illustrates increasing industry focus on this distribution channel.

There will be increasing demand for advanced wound healing products where staffing levels and resources do not permit proper pressure injury prevention and where reimbursement policies reward achievement of pressure injury-free status. Manufacturers should be able to justify the total cost of treatment and the number of dressing changes with their product in order to capture and retain market share. There will likely be opportunities for smaller specialized manufacturers to satisfy unmet needs.

Strategic Growth Opportunities in the Bedsore Dressing Market

Commercial trends will develop due to changes in the healthcare marketplace, including rising geriatric populations and heightened awareness of hospital-related pressure injuries. Simultaneously, the home-based healthcare market is expected to grow. Between 2024 and 2026, Lucintel expects the home-based healthcare market will promote the use of preventive wound-healing products and services, and contractual agreements based on clinical evidence.

• Home-Based Wound Care: In January 2025, the Centres for Medicare and Medicaid Services (CMS) reported that nearly 11 million Medicare beneficiaries received skilled home health services during the year. Going forward, the number of beneficiaries is expected to increase as more elderly and frail patients are treated outside of the hospital and other post-acute care settings.
• Antimicrobial Products: Products that integrate antimicrobial and other products to prevent pressure ulcers and other wound infections are expected to grow and gain market share. The CDC's March 2025 report reinforced the need to control and prevent health-care associated pressure injuries.
• Smart Monitoring: Smart dressing technology along with wireless, real-time documentation of assessments, enables clinical staff to proactively manage moisture and pressure. The FDA's digital health product recognized program, which authorizes software for commercial distribution, has more than 1,000 active product listings as of February 2025. The remote monitoring ecosystem continues to grow. The technology will reduce the need for in-person assessments and nursing visits.
• Sustainable Materials: The NHS, along with other healthcare systems, continues to encourage the development of supplier-provided products and services that support their commitment to sustainability and reducing their environmental impact. Tendering will reward suppliers that incorporate sustainable and biodegradable materials into their product offerings.
• Emerging Market Distribution: There are many opportunities in underdeveloped markets of Latin America, the Middle East and Asia to manufacture and distribute products to prevent and treat pressure injuries. As of June 2025, an estimated 2.5 billion individuals did not have access to essential medical care and support.

The market for pressure injury prevention products is growing. Within the next five years, the most successful companies will establish and maintain strong clinical evidence to demonstrate the effectiveness of their products and incorporate features that help staff document the prevention of wound recurrence.

Bedsore Dressing Market Drivers and Challenges

The market for bedsore dressing is positively impacted by a number of drivers including increased patient vulnerability, greater geriatric population, and increased health care spending. Newer innovations and the focus on elimination of health care associated conditions have created an environment for entrance of new products in this market. There is a growing demand for dressings in health care settings to promote healing and prevent healthcare associated infections. Other factors affecting this market include product price, market acceptance, and level of competition. Lucintel reports that the use of specialty materials and home health care are growth opportunities for the health care industry. However, the health care industry is challenged to ensure adequacy, equity and accessibility of health care services, products and facilities.

The factors responsible for driving this market include:

• Customer Demand: As the world's population of elderly people and diabetics increases, and as more and more people require long term care, so does the market demand for products to either prevent or heal the related conditions. In 2025 the United Nations stated that the 65 years and older population of the world was over 1 billion and represented more than 10% of the world's total population. Between now and the next few years it is anticipated that the care and treatment of related conditions will increase. It is expected that new products to provide evidence of the achievement of end results and to reduce the occurrence of conditions for which there should be no occurrence, will be preferred by hospitals and other care facilities.
• Technological Advances: The market demand is expected to increase for products that provide better protection for health care related conditions. It is anticipated that new products to achieve better protection will utilize new technology to reduce the number of necessary dressing changes. It is expected that some of the new products to achieve better protection will be integrated with sensors and other electronic technology. New products will focus on improving gauze products.
• Regulatory and Clinical Support: Pressure injuries are on various hospital quality improvement programs and are the focus of many regulatory initiatives. As part of the Hospital-Acquired Condition Reduction Program, as of January 2025, hospitals in the bottom tier faced a 1% reduction in their Medicare payment. Pressure to improve programs to prevent and heal pressure injuries, coupled with potential loss of Medicare reimbursement, drives the adoption of more effective products and interventions. The next three to five years will see further attention by regulatory bodies to pressure injury prevention and healing. Companies with products that demonstrate safety and efficacy will be favoured. Similar to other medical devices, pressure injury prevention and healing products will be evaluated to meet basic requirements to allow their use.
• Sustainability: The European healthcare sector is focusing on various sustainability initiatives including a shift to products with less packaging and a greater focus on the overall life cycle of the product. As of March 2025, many of these initiatives were not mandated, and in combination with risk of infection, challenged product design. Pressure will continue to be placed on manufacturers to create products that minimize their ecological impact while retaining safety and efficacy. This will be especially true in the bedsore dressing market, where sustainability and other initiatives will impact the final outcome and design of products.
• Manufacturing Efficiency and Cost Advantages: Improvements in supply chain management and manufacturing methods have allowed medical product suppliers to further control costs and increase product availability. Consolidation of procurement strategies by healthcare systems in April 2025 to achieve more favorable prices and reliability of supply created incentives to increase contracts volumes. Reducing cost and improving availability of advanced wound care products may encourage substitution from less sophisticated products.

The challenges facing this market include:

• High Cost of Products: The high costs associated with the manufacturing of advanced wound care products make them inaccessible and impede their adoption. Healthcare systems and patients are often forced to use more basic and less effective products. Negotiations over unit prices by healthcare providers in May 2025 reflected continued constraints on reimbursement. During this period, advancing health economics and supporting evidence to justify the use of more expensive wound care products to prevent infection and reduce the average length of stay would improve the adoption of more sophisticated products. Absence of such evidence would likely restrain the market.
• Variability in Reimbursement and Clinical Adoption: Uncertainty in reimbursement varies at different levels of the health system. For instance, inequities exist across different countries, health insurance programs, hospitals and other health facilities. As of June 2025, there were equitable challenges in third-party reimbursement for products used to manage advanced wound-healing locations across the inpatient, outpatient and home-based settings, creating further inequities in access and use across the health system. Until 2030, payers are not expected to reimburse based on the total costs of the treatment, and as a result, dressings will continue to be the highest cost-shifting item for product manufacturers. Companies should invest in educational programs to influence clinical judgment in using advanced wound-healing products.
• Supply and Distribution Challenges: Manufacturing of bedsore (or pressure injury) dressings requires the use of advanced materials (e.g., polymers and adhesives), fibres (e.g., non-wovens) and substances (e.g., antimicrobials) to create products that achieve the expected clinical outcomes. In 2025, multiple suppliers of health-care products maintained additional stock to meet the expected demand for their products. Health care distributors and suppliers are confronted with unprecedented challenges in the transportation and distribution of health care products.

It is expected that in the next 5 to 10 years raw material and energy costs will increase, make supply more unstable, and increase the failure rate of products. At the same time more and changing regulations will increase the cost of manufacturing. Because of these factors, manufacturers will need to make better, stronger, and more transparent systems. Unless they are able to do this, smaller and medium sized companies will find it harder to compete with larger, multinational companies. The bed sore dressing market should grow due to increased medical innovation and larger and older patient populations. Additionally, more beds in hospitals means an increased focus on bed sore prevention. There are opportunities for bed sore dressing manufacturers to differentiate their products based on innovation and production sustainability. There are a number of barriers to market like the high costs of dressings and a spotty reimbursement market. These barriers limit the rate of dressings adoption. The most innovative and differentiating products will successfully gain a larger share of the market.

List of Bedsore Dressing Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies bedsore dressing market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bedsore dressing market companies profiled in this report include-

• 3M
• Molnlycke
• Smith & Nephew
• Convatec
• B. Braun
• Paul Hartmann
• Coloplast
• Urgo Group
• Cardinal Health
• Medline Industries

Bedsore Dressing Market by Segment

The study includes a forecast for the global bedsore dressing market by type, application, and region.

Bedsore Dressing Market by Type [Value ($B) from 2019 to 2035]:

• Foam Dressings
• Hydrocolloid Dressings
• Alginate Dressings
• Hydrogel Dressings
• Others

Bedsore Dressing Market by Application [Value ($B) from 2019 to 2035]:

• Hospital
• Clinic
• Pharmacy
• Online

Bedsore Dressing Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bedsore Dressing Market

Growth in the bedsore dressing market is attributable to the reforms in the acute care segment of the health care system, focused manufacturing, and advanced wound care products. It is expected that between 2025 and 2027, investment and procurement priorities would be on products and services that offer sufficient clinical evidence, increase supply chain security, and help alleviate the workload of the nursing staff.

• United States: It is expected that in 2026, reimbursement and third-party payer policies will prioritize the use of wound products that demonstrate clinical outcomes. In August 2025, the Centre for Medicare and Medicaid Services announced an update to its payment policy to healthcare providers that would increase reimbursement rates to healthcare providers by an estimated 2.4%. In 2025, the advanced wound care product company, Specialty Networks was acquired by Cardinal Health.
• China: In 2025, the Chinese government extended its policy of mandatory centralized procurement and local replacement of medical device products. The 2025 budget of the Chinese government increased to an estimated 6.05 trillion Chinese Yuan. This fostered the development of medical products including wound care products.
• Germany: By March 2025, Hartmann reported a group sale of more than €2.5 billion, representing a significant growth from the previous year. As Germany finalizes the European Medical Device Regulation (EMDR), companies are aligning their manufacturing with EMDR requirements. In the near term (within 3-5 years), the implementation of EMDR will regulate manufacture and import of medical devices in the European market. During this time, quality systems, regulatory submissions and their acceptances will play a critical role in medical device companies' access to hospital tenders in the European market.
• India: In February 2025, the Department of Pharmaceuticals estimated the Indian medical device market at approximately USD 11 billion. The nation's medical device policy, combined with initiatives to promote local device manufacturing, will facilitate the development of Indian manufactured pressure injury dressings, and advance wound care devices.
• Japan: With effect from April 2025, the Japanese government revised its reimbursement policy to prioritize home-based and community-based health and social services. Further, the policy aims to transform the health and social care system to provide quick and efficient services. This policy will create more demand for wound care products and services in the community and home based settings.

Features of the Global Bedsore Dressing Market

• Market Size Estimates: bedsore dressing market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: bedsore dressing market size by type, application, and region in terms of value ($B).
• Regional Analysis: bedsore dressing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the bedsore dressing market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bedsore dressing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bedsore dressing market by type (foam dressings, hydrocolloid dressings, alginate dressings, hydrogel dressings, and others), application (hospital, clinic, pharmacy, and online), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?